SusanSwindellsMD
Infectious Disease • Omaha, NEProfessor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Are you Dr. Swindells?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-2666Fax+1 402-559-2677
Summary
- Dr. Susan Swindells, MD is an infectious disease specialist in Omaha, Nebraska. She is currently licensed to practice medicine in Nebraska, Iowa, and Ohio. She is affiliated with Nebraska Medicine - Nebraska Medical Center and is a Professor at University of Nebraska Medical Center College of Medicine.
Education & Training
University of WashingtonResidency, Family Medicine, 1979 - 1980
University of London Faculty of MedicineClass of 1977
Certifications & Licensure
NE State Medical License 1991 - 2026
IA State Medical License 1995 - 2014
OH State Medical License 1988 - 2004
WI State Medical License 1985 - 2001
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Atazanavir/Ritonavir Maintenance Therapy Start of enrollment: 2004 Jul 01
- Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals Start of enrollment: 2009 Dec 01
- Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsAcceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United StatesJoshua P. Havens, Kimberly K. Scarsi, Harlan Sayles, Donald G. Klepser, Susan Swindells
Open Forum Infectious Diseases. 2018-11-26 - 24 citationsHigh-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, Stefan V. Goldberg, Lorna Bozeman
Contemporary Clinical Trials. 2020-01-22 - 33 citationsModeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideJacques H. Grosset, Deepak V. Almeida, Paul J. Converse, Sandeep Tyagi, Si Yang Li
Proceedings of the National Academy of Sciences of the United States of America. 2012-09-11
Press Mentions
UNMC for the RecordOctober 8th, 2021- Gilead’s Lenacapavir: HIV Prospects Strongest in Long-Acting Combos with Merck’s IslatravirAugust 25th, 2021
- HIV: Failed Viral Suppression in CAB/RPV Linked to Three Risk FactorsJuly 27th, 2021
- Join now to see all
